Riccardo Palmisano

CEO MolMed, Presidente Assobiotec, AD Genzyme, Business Strategy & Development Sanofi, VP GlaxoSmithKlein, AD Shire Pharmaceuticals

Johann Tse

Founder Aquarian Capital, Director for international M&A Yum! Brands, Corporate Strategic Planning Rohm and Haas, General manager Swire Group

Simona Roggero

Physician, ten years of clinical research experience in hematology, she has coordinated international cooperation projects for congenital anemia. As Scientific director at Cardiovascular Lab, she has supported the launch of several projects in the medtech field

Giuseppe Donagemma

Senior advisor at eVolution Networks, Chairman at Avanseus and Satispay, Board member at Assia and Inbot. Former VP Europe Networks Samsung, Senior VP Nokia, Chairman Nokia Italy, Siemens, Alix Partners

Hadi Abderrahim

Head of Strategy Healthcare at Qatar Foundation Research & Development, Director and Head of Genetics and Biomarkers at MerkSerono, Head of Genetics & Genomic Platforms at Genset Corp. and later Serono Genetics Institute

Hiroaki Tanaka

Head of Personalized medicine at Debiopharm, Head of Stratified Medicine at MerkSerono, Director Market Development & Strategy at Serono, VP Bioinformatics at Genset Corp

Claudio Giuliano

Professional experience: The Carlyle Group, Bain & Company, Hewlett Packard. Education: MBA from Insead (Fontainebleau, France), MS Electronic Engineering (Politecnico di Torino)

Claudio Rumazza

Giovanni Leo

Professional experience: VP R&D at St Jude Medical, founder at Endosense, Acrostak, Isotopes and Metals, LeCroy, CERN. Education: MS Management Engineering (Politecnico di Milano), EMBA Management and Corporate Finance (HEC Lausanne)

William R. Brody

Former President of Salk Institute for Biological Studies and Johns Hopkins University, physician-scientist (cardiovascular, radiology), serial entrepreneur and academic